169
Views
6
CrossRef citations to date
0
Altmetric
Review

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension

, &
Pages 1331-1346 | Published online: 22 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Marcella Nebbioso, Mariasilvia Evangelista, Aloisa Librando, Dario Di Blasio & Nicola Pescosolido. (2012) Fixed topical combinations in glaucomatous patients and ocular discomfort. Expert Opinion on Pharmacotherapy 13:13, pages 1829-1835.
Read now
Robert M Feldman, Nicholas P Bell & Kundandeep S Nagi. (2011) Control of intraocular pressure fluctuation: are combination drugs more effective?. Expert Review of Ophthalmology 6:2, pages 151-154.
Read now

Articles from other publishers (4)

Sally Miller, Shashank Kulkarni, Alex Ciesielski, Spyros Nikas, Ken Mackie, Alexandros Makriyannis & Alex Straiker. (2018) Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure. Pharmaceuticals 11:2, pages 50.
Crossref
Isabel Rodríguez, José Antonio Vázquez, Lorenzo Pastrana & Vitaliy V. Khutoryanskiy. (2017) Enhancement and inhibition effects on the corneal permeability of timolol maleate: Polymers, cyclodextrins and chelating agents. International Journal of Pharmaceutics 529:1-2, pages 168-177.
Crossref
Aparna A. Shah, Yasha Modi, Benjamin Thomas, Sarah R. Wellik & Anat Galor. (2015) Brimonidine Allergy Presenting as Vernal-like Keratoconjunctivitis. Journal of Glaucoma 24:1, pages 89-91.
Crossref
Sukhsagar Ratol, Rani Walia & Mridu Chaudhry. (2012) A Comparative Analysis of the Efficacy and Safety of fixed Combinations of Latanoprost/Timolol vs Dorzolamide/Timolol in Primary Open Angle Glaucoma or Ocular Hypertension. Journal of Postgraduate Medicine, Education and Research 46:4, pages 172-176.
Crossref